|
Tweet | ||
260 | Mon, 8/10/2015, 2:00 PM - 3:50 PM | CC-614 | |
Missing Data II — Contributed Papers | |||
Biopharmaceutical Section , Government Statistics Section | |||
Chair(s): Rajesh Nair, FDA | |||
2:05 PM | A Two-Stage, Phase II Clinical Trial Design with Nested Criteria for Early Stopping and Efficacy — Daniel Zelterman, Yale University ; Michael Kane, Yale University ; Michelle DeVeaux, Yale University | ||
2:20 PM | Similarity Assessment of Chromatographic Fingerprint of Botanical Products — Xiaoyu Dong, FDA ; Yi Tsong, FDA ; Zhuang Miao, FDA ; Jinhui Dou, FDA | ||
2:35 PM | Improving Power for Biomarker Detection with Joint Modeling of Multiple Endpoints in Early-Phase Clinical Trials — Qianying Liu, Sanofi ; Glen Laird, Sanofi ; Wei Zheng, Sanofi | ||
2:50 PM | An Empirical Bayesian Approach to Bioequivalence Studies — Li He, Merck Research Laboratories ; Robert Capen, Merck Research Laboratories | ||
3:05 PM | Automated High-Dimensional Cytometry Analysis to Elucidate Phenotypic and Functional Modulation in Immuno Cellular Subpopulations — Shubing Wang, Merck ; An Chi, Merck ; Yujie Qu, Merck | ||
3:20 PM | Sample Size Calculation in Clinical Trials with Mixed Binary and Continuous Co-Primary Endpoints Modeled by Gaussian Copulas — Beilei Wu, PAREXEL International ; Alexander de Leon, University of Calgary ; Daniel Bonzo, PAREXEL International | ||
3:35 PM | Bayesian Prediction Model of Event Times in Randomized Clinical Trial — Jiang Li, Novartis ; Wentao Feng, Novartis ; Satrajit Roychoudhury, Novartis Pharmaceuticals |
For program information, contact the JSM Registration Department or phone (888) 231-3473.
For Professional Development information, contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
2015 JSM Online Program Home
ASA Meetings Department
732 North Washington Street, Alexandria, VA 22314
(703) 684-1221 • meetings@amstat.org
Copyright © American Statistical Association.